Date post: | 18-Dec-2014 |
Category: |
Education |
Upload: | barry-duncan |
View: | 848 times |
Download: | 2 times |
www.heartandsoulofchange.com 4/3/2011
1
Controversies of the Day
Barry Duncan,Barry Duncan, Psy.DPsy.D. www.heartandsoulofchange.com. www.heartandsoulofchange.com954.721.2981954.721.2981 www.whatsrightwithyou.comwww.whatsrightwithyou.com
[email protected]@comcast.net
Threats to Our Identity
www.heartandsoulofchange.com 4/3/2011
2
Take Clients at Face ValueBut Nothing Else
Take Clients at Face ValueBut Nothing Else
Several issuesthreaten our identity
Bottom Line: Look atit yourself and draw
your own conclusions
Several issuesthreaten our identity
Bottom Line: Look atit yourself and draw
your own conclusions
Controversial Issues and ThreatsGotta Dig Deeper
Controversial Issues and ThreatsGotta Dig Deeper
Third PartyReimbursement Trends
Evidence Based Practice
PsychotropicMedications
Psychotherapy and theMedical Model
Third PartyReimbursement Trends
Evidence Based Practice
PsychotropicMedications
Psychotherapy and theMedical Model
www.heartandsoulofchange.com 4/3/2011
3
Therapists and Mangled CareWhine, Whine, Whine
Therapists and Mangled CareWhine, Whine, Whine
Things are relative…WhenCHAMPUS started, such outrage.
Paid less than others & had theaudacity to require a tx plan atsession 24! Many could not workfor such measly pay or with suchunreasonable demands.
To any therapist today, whatCHAMPUS paid then with suchlimited oversight, would be todie for.
Things are relative…WhenCHAMPUS started, such outrage.
Paid less than others & had theaudacity to require a tx plan atsession 24! Many could not workfor such measly pay or with suchunreasonable demands.
To any therapist today, whatCHAMPUS paid then with suchlimited oversight, would be todie for.
All Downhill From ThereAll Downhill From There
We didn’t work w/ 3rd partypayers to address costs, wedemonized them.
They deserve their DarthVader status. But we didn’toffer alternatives. Mainlyresponded with righteousindignation.
But not going away… Instead of fighting, join
them at the table; data canhelp us be “players”
We didn’t work w/ 3rd partypayers to address costs, wedemonized them.
They deserve their DarthVader status. But we didn’toffer alternatives. Mainlyresponded with righteousindignation.
But not going away… Instead of fighting, join
them at the table; data canhelp us be “players”
www.heartandsoulofchange.com 4/3/2011
4
Stepping UpReturn on Investment
Stepping UpReturn on Investment
Conversant in the language(proof of value, return oninvestment); responsibility forcost & effectiveness.
Managed care has reason forconcern: dropout, therapistand treatment variability.
Collecting data & usingfeedback solves concerns.
These advantages can bebargaining chips. Efficiencyshould increase the value ofour services.
Conversant in the language(proof of value, return oninvestment); responsibility forcost & effectiveness.
Managed care has reason forconcern: dropout, therapistand treatment variability.
Collecting data & usingfeedback solves concerns.
These advantages can bebargaining chips. Efficiencyshould increase the value ofour services.
Darth Vader Is Still Darth VaderHow Will They Use the Data
Darth Vader Is Still Darth VaderHow Will They Use the Data
Some will employ thedata to improveoutcomes, i.e., provideimmediate feedback soyou can adjust tobenefit your clients.
Giving you feedback toimprove your servicesspeaks to an interest inthe quality of theservices delivered.
Some will employ thedata to improveoutcomes, i.e., provideimmediate feedback soyou can adjust tobenefit your clients.
Giving you feedback toimprove your servicesspeaks to an interest inthe quality of theservices delivered.
www.heartandsoulofchange.com 4/3/2011
5
Other PurposesOther Purposes
Clinician profiling, removingtherapists from providerpanels or limiting referrals.
Or, to steer referrals or payhigher rates—or “P4P”
Client welfare often invokedas an explanation—clientssteered have best chancefor success. But even thebest don’t benefit up to athird of their clients. P4Pdoes not address clientsreceiving services now.
Clinician profiling, removingtherapists from providerpanels or limiting referrals.
Or, to steer referrals or payhigher rates—or “P4P”
Client welfare often invokedas an explanation—clientssteered have best chancefor success. But even thebest don’t benefit up to athird of their clients. P4Pdoes not address clientsreceiving services now.
P4P Doesn’t WorkWet Blanket
P4P Doesn’t WorkWet Blanket
P4P Threatens OurIdentity; Puts Us InCompetition w/EachOther—Advantage Gainedat Someone’s expense
Kills the Spirit…EverybodyCan Get Better
We are motivated bygetting better at what wedo…
P4P Threatens OurIdentity; Puts Us InCompetition w/EachOther—Advantage Gainedat Someone’s expense
Kills the Spirit…EverybodyCan Get Better
We are motivated bygetting better at what wedo…
www.heartandsoulofchange.com 4/3/2011
6
Bottom LineBecome a Player
Bottom LineBecome a Player
Become a player.
Collect data, takeresponsibility, learn thelanguage of business, &negotiate higher rates.
Oppose collection ofdata w/o feedback.Voice concerns that P4Pwill kill the spirit ofoutcome management.
Become a player.
Collect data, takeresponsibility, learn thelanguage of business, &negotiate higher rates.
Oppose collection ofdata w/o feedback.Voice concerns that P4Pwill kill the spirit ofoutcome management.
Take Clients at Face ValueBut Nothing Else
Take Clients at Face ValueBut Nothing Else
Two approaches: ESTsor EBTs and EBP
One establishes criteriabased on RCTs andcreates lists
Other describesprocess of applyingevid. & incl. participants
Two approaches: ESTsor EBTs and EBP
One establishes criteriabased on RCTs andcreates lists
Other describesprocess of applyingevid. & incl. participants
www.heartandsoulofchange.com 4/3/2011
7
Evidence Based PracticeWhat’s the Hubbub?
Evidence Based PracticeWhat’s the Hubbub?
All approaches have validways to help clients.Makes sense to learnmultiple ways.
Also makes sense to be“evidence based”
In truth, no one says,“Evidence, smevidence!”
Like not believing in Momor apple pie. So what isthe controversy about?
All approaches have validways to help clients.Makes sense to learnmultiple ways.
Also makes sense to be“evidence based”
In truth, no one says,“Evidence, smevidence!”
Like not believing in Momor apple pie. So what isthe controversy about?
Evidence Based PracticeA Little History: EST to EBP
Evidence Based PracticeA Little History: EST to EBP
1993 apa guidelines Magic bullets to counteract
magic pills: ESTs & Div 12;increased rec. therapyefficacy, but
Promulgated grossmisinterpretations and nowoften wielded as amandate for competentand ethical practice.
That’s the controversy.Intent is not to demonize
1993 apa guidelines Magic bullets to counteract
magic pills: ESTs & Div 12;increased rec. therapyefficacy, but
Promulgated grossmisinterpretations and nowoften wielded as amandate for competentand ethical practice.
That’s the controversy.Intent is not to demonize
www.heartandsoulofchange.com 4/3/2011
8
Be SkepticalLike My Little Friend
Be SkepticalLike My Little Friend
Can be tedious
Worth it to countermandates & practiceaccording to clientpreferences and benefit.
ESTs suggest a therapistidentity based on technicalacumen in administeringmanualized, cookie cutterinterventions
Can be tedious
Worth it to countermandates & practiceaccording to clientpreferences and benefit.
ESTs suggest a therapistidentity based on technicalacumen in administeringmanualized, cookie cutterinterventions
No Data Supports Such EdictsThe Question: Is It a Fair Contest
No Data Supports Such EdictsThe Question: Is It a Fair Contest
Dodo: most replicated; nospecific effects; efficacy overplacebo, sham, or no tx isnot differential efficacy.
In few claiming superiority:Is it a fair contest?
Comparing 2 approachesintended to be therapeuticadministered in = amts bythose who believe in whatthey are doing & equallysupported—from same pool?
Dodo: most replicated; nospecific effects; efficacy overplacebo, sham, or no tx isnot differential efficacy.
In few claiming superiority:Is it a fair contest?
Comparing 2 approachesintended to be therapeuticadministered in = amts bythose who believe in whatthey are doing & equallysupported—from same pool?
www.heartandsoulofchange.com 4/3/2011
9
Whose Evidence Is It?Allegiance Effects
Whose Evidence Is It?Allegiance Effects
At least 40% of anyobserved effect isattributable to the beliefin (allegiance to) theapproach by theresearchers…TDCRP
Even meagerEven meagerdifferences disappeardifferences disappearwhen researcherwhen researcherallegiance isallegiance iscontrolled…controlled…
At least 40% of anyobserved effect isattributable to the beliefin (allegiance to) theapproach by theresearchers…TDCRP
Even meagerEven meagerdifferences disappeardifferences disappearwhen researcherwhen researcherallegiance isallegiance iscontrolled…controlled…
PMTO(Ogden & Hagan, 2008)
PMTO(Ogden & Hagan, 2008)
PMTO effective in reducingparent-rep. child externalizingproblems, improving teacher-rep. social competence, &enhancing parental disciplineover TAU.
“The findings thus indicate thatPMTO is an effective treatmentprogram…and moreover thatan evidence-based treatmentprogram can be transportedsuccessfully…” (p. 617).
PMTO effective in reducingparent-rep. child externalizingproblems, improving teacher-rep. social competence, &enhancing parental disciplineover TAU.
“The findings thus indicate thatPMTO is an effective treatmentprogram…and moreover thatan evidence-based treatmentprogram can be transportedsuccessfully…” (p. 617).
Ogden, T., & Hagen, K.A. (2008). Treatment effectiveness of ParentManagement Training in Norway: A randomized controlled trial ofchildren with conduct problems. Journal of Consulting and ClinicalPsychology, 76(4), 607-621.
www.heartandsoulofchange.com 4/3/2011
10
The DataPMTO v TAU
The DataPMTO v TAU
16 measures—only 4 found adifference
On 1 of 4 (CBCL Total), thedifference was 1.92 points.
On CBCL Ext., difference was1.53 points. Clinical significancequestionable at best.
Differences by age. Superiorfinding for PMTO on 4/16measures for 7 & younger only.None on 15/16 measures for 8& older; 1 favored TAU.
16 measures—only 4 found adifference
On 1 of 4 (CBCL Total), thedifference was 1.92 points.
On CBCL Ext., difference was1.53 points. Clinical significancequestionable at best.
Differences by age. Superiorfinding for PMTO on 4/16measures for 7 & younger only.None on 15/16 measures for 8& older; 1 favored TAU.
In Addition to These UnderwhelmingResults…Unfair Contest
In Addition to These UnderwhelmingResults…Unfair Contest
PMTO therapists: 18 monthstraining & ongoing sup. duringstudy: TAU therapists received notraining, support, or sup.
Dose favored PMTO 40 v. 21 hrs.
No findings on 12/16 measures,no effects children 8 & over,combined with differential training& support of the 2 therapistgroups & unequal doses of tx castdoubt on this study’s conclusions.
PMTO therapists: 18 monthstraining & ongoing sup. duringstudy: TAU therapists received notraining, support, or sup.
Dose favored PMTO 40 v. 21 hrs.
No findings on 12/16 measures,no effects children 8 & over,combined with differential training& support of the 2 therapistgroups & unequal doses of tx castdoubt on this study’s conclusions.
www.heartandsoulofchange.com 4/3/2011
11
Trauma Focused CBTUnfair Contests
Trauma Focused CBTUnfair Contests
Child Centered Treatment(CCT), the comparison tx is nota fair comparison—therapistsdid not see the kids & parentstogether, TF-CBT therapistssaw kids and parents together3 x out of the 12 sessions. Notreasonable care…
CCT condition did not provideadvice or suggestions to kids orparents. Not a real tx.
Reactive measures; 5 of 13
Child Centered Treatment(CCT), the comparison tx is nota fair comparison—therapistsdid not see the kids & parentstogether, TF-CBT therapistssaw kids and parents together3 x out of the 12 sessions. Notreasonable care…
CCT condition did not provideadvice or suggestions to kids orparents. Not a real tx.
Reactive measures; 5 of 13Cohen, J. A., Deblinger, E., Mannarino, A. P., & Steer, R. A. (2004). A multisite, randomized controlled trial for children with sexualabuse-related PTSD symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 43(4), 393-402.
APA Definition of EBPAPA Definition of EBP
Evidence-basedpractice is theintegration of the bestavailable research withclinical expertise in thecontext of clientcharacteristics, culture,and preferences(American Psychologist,May 2006).
Evidence-basedpractice is theintegration of the bestavailable research withclinical expertise in thecontext of clientcharacteristics, culture,and preferences(American Psychologist,May 2006).
www.heartandsoulofchange.com 4/3/2011
12
APA RecommendationsAPA Recommendations
Decisions should be made incollaboration with the client,based on the best evidence
Most effective whenresponsive to the client’sstrengths, cultural context,and preferences.
Responses are variable.Therefore, ongoingmonitoring of client progressand adjusting as needed isessential
Decisions should be made incollaboration with the client,based on the best evidence
Most effective whenresponsive to the client’sstrengths, cultural context,and preferences.
Responses are variable.Therefore, ongoingmonitoring of client progressand adjusting as needed isessential
EST/EBTs offers choices forclients—but are merelylenses that may or may notfit the client’s frame andprescription. Methods andmodels are neither deitynor demon, but are usefulmetaphorical accounts ofhow people can change.
But any mandates…
EST/EBTs offers choices forclients—but are merelylenses that may or may notfit the client’s frame andprescription. Methods andmodels are neither deitynor demon, but are usefulmetaphorical accounts ofhow people can change.
But any mandates…
No Silver Bullet Cures
www.heartandsoulofchange.com 4/3/2011
13
A Mountain of ManureA Mountain of Manure
Lopsided ContestLook for YourselfLopsided ContestLook for Yourself
I have never seen anadvantage of anyapproach over another
(or TAU) that wasn’t alopsided contest
that had its winnerpredetermined.
www.heartandsoulofchange.com 4/3/2011
14
DBTShould It Be Prosecutable?
DBTShould It Be Prosecutable?
Using vague,unstandardizedmethods to assisttroubled clients ‘shouldbe prosecutable’ insome cases, said Dr.Marsha Linehan (Carey,2005, p. 2).
Linehan, M. et al (2006) Two-Year Randomized Control Trial and Follow up of DBT.Archives of General Psychiatry, 63, 757-766.
•NIMH funded study of DBT:• Compared DBT to servicesoffered by “community-nominated” treatment experts;• Community experts:
•Received no training, supervision, orconsultation;
•No control of type, amount, or qualityof services .
•Provided significantly less directservice than DBT therapists.
•DBT therapists:•Received 45 hours of specializedtraining;
•Pre- and during-study supervision.
•Gave 95 (38 x 2½) more hours ofcontact dedicated to keeping peopleout of the hospital
DBT:DBT:What do the data say?
www.heartandsoulofchange.com 4/3/2011
15
The Truth Is in the Tables
Smoke and MirrorsReal World Applications
Smoke and MirrorsReal World Applications
DBT for “BPD”
In a large CMHC servingSPMI clients: Of 382eligible by dx, only 25(6.5%) thought it was forthem; 25% of thosedropped out beforeprogram started; another25% dropped out…is itworth the cost?
DBT for “BPD”
In a large CMHC servingSPMI clients: Of 382eligible by dx, only 25(6.5%) thought it was forthem; 25% of thosedropped out beforeprogram started; another25% dropped out…is itworth the cost?
Haynes, M. (2006). Real world applications of evidence based practice.Heart and Soul of Change 3. Bar Harbor, ME.
www.heartandsoulofchange.com 4/3/2011
16
APA Conclusions and theBottom Line…
APA Conclusions and theBottom Line…
Outcome not guaranteedregardless of evidence
Challenge statements thatuse EBTs to mandate orreimburse.
Know about dodo verdict &unfair contests in research.
Educate others about APAdefinition & importance ofmeasuring client response.
Outcome not guaranteedregardless of evidence
Challenge statements thatuse EBTs to mandate orreimburse.
Know about dodo verdict &unfair contests in research.
Educate others about APAdefinition & importance ofmeasuring client response.
Mandatesdon’tmakeempiricalsense
NOT ANTI-EBT or ESTNOT ANTI-EBT or EST
Calling for a more sophisticated clinician whochooses from a variety of orientations andmethods to best fit client preferences andcultural values. Although there has not beenconvincing evidence for differential efficacyamong approaches, there is indeed differentialefficacy for the client in the room now—therapists need expertise in a broad range ofintervention options, including ESTs.
Calling for a more sophisticated clinician whochooses from a variety of orientations andmethods to best fit client preferences andcultural values. Although there has not beenconvincing evidence for differential efficacyamong approaches, there is indeed differentialefficacy for the client in the room now—therapists need expertise in a broad range ofintervention options, including ESTs.
www.heartandsoulofchange.com 4/3/2011
17
Reminds Me ofAnimal FarmReminds Me ofAnimal Farm
Some therapiesare more equalthan others
Some therapiesare more equalthan others
The Medical Model EquationThe Medical Model EquationIs It Your Identity?Is It Your Identity?
The Medical Model EquationThe Medical Model EquationIs It Your Identity?Is It Your Identity?
DiagnosisDiagnosis
++
Prescriptive TreatmentPrescriptive Treatment
==
Cure or SymptomCure or SymptomAmeliorationAmelioration
DiagnosisDiagnosis
++
Prescriptive TreatmentPrescriptive Treatment
==
Cure or SymptomCure or SymptomAmeliorationAmelioration
www.heartandsoulofchange.com 4/3/2011
18
The Medical ModelFighting the Borg?The Medical Model
Fighting the Borg?
MM is not the Borg, nor amI Captain Picard.
Psychotherapy, however, isnot a medical, it isrelational.
Never challenged on that.
Yet, MM rules as adescription of what we do.Ironically, its assumptionsand practices are notsupported by the data.
MM is not the Borg, nor amI Captain Picard.
Psychotherapy, however, isnot a medical, it isrelational.
Never challenged on that.
Yet, MM rules as adescription of what we do.Ironically, its assumptionsand practices are notsupported by the data.
DiagnosticDiagnostic DysDys--OrderOrder
Poor ReliabilityPoor Reliability
Unknown ValidityUnknown Validity
Does not predict LOS or outcomeDoes not predict LOS or outcome
Little help in treatment selectionLittle help in treatment selection
Surveys consistently find that MHPsSurveys consistently find that MHPsdo not like it or find it useful…do not like it or find it useful…
Kirk, S.A., & Kutchins, H. (1992). The selling of DSM: The rhetoric of science in psychiatry. New York: AldineDuncan, B., Miller, S., & Sparks, J. (2004). The Heroic Client. San Francisco: Jossey-Bass.
www.heartandsoulofchange.com 4/3/2011
19
“Psychotherapy is the only form of treatmentwhich, at least to some extent, appears to createthe illness it treats” Jerome Frank (Frank, 1961,p. 7).
Reliability: “To say that we've solved thereliability problem is just not true…It's beenimproved. But if you're in a situation with ageneral clinician it's certainly not very good.There's still a real problem, and it's not clearhow to solve the problem" Robert Spitzer, leadeditor of DSM III (Spiegel, 2005, p. 63).
Validity: “There is no definition of a mentaldisorder. It’s bullshit. I mean, you just can’tdefine it… these concepts are virtuallyimpossible to define precisely with bright lines atthe boundaries.” Allen Francis, lead editor ofDSM IV (Greenberg, 2010, p. 1).
Quotable Quotes about Diagnosis
•Creates the Illness•Reliability not good•It’s bullshit
DiagnosisFinal Comment
DiagnosisFinal Comment
Remains a fixed part ofgraduate training programs,a prominent feature of ESTs,and a prerequisite forfunding in most mentalhealth and substance abusedelivery systems—allengendering an illusion ofscientific aura & clinicalutility that far overreachesthe DSM’s deeply flawedinfrastructure.
Remains a fixed part ofgraduate training programs,a prominent feature of ESTs,and a prerequisite forfunding in most mentalhealth and substance abusedelivery systems—allengendering an illusion ofscientific aura & clinicalutility that far overreachesthe DSM’s deeply flawedinfrastructure.
www.heartandsoulofchange.com 4/3/2011
20
The Beat Goes On: MH ParityGood But
The Beat Goes On: MH ParityGood But
Just like FOC leg. enslaved us toreimbursement by dx & themedical way we talk, paritypromises further bondage.
Payers still set fees. Have tocover the costs of equal accesssomehow: reducing profit?
Negotiating based on benefit, ora fixed no. of sessions in returnfor better rates & autonomywould be moot. Parity does notaddress outcome.
Just like FOC leg. enslaved us toreimbursement by dx & themedical way we talk, paritypromises further bondage.
Payers still set fees. Have tocover the costs of equal accesssomehow: reducing profit?
Negotiating based on benefit, ora fixed no. of sessions in returnfor better rates & autonomywould be moot. Parity does notaddress outcome.
Medical Model: Doesn’t Fit Me, MyExperience, or the Data
Medical Model: Doesn’t Fit Me, MyExperience, or the Data
Not pts with illnesses requiringtx from experts w/powerfulinterventions. Not bestdescribed by Killer Ds. Therapyis not model & technique.
Identity lies outside dx,prescriptive tx, cure, &reflects the interpersonalnature of the work & theconsumer’s perspective of thebenefit & fit of services.
Not pts with illnesses requiringtx from experts w/powerfulinterventions. Not bestdescribed by Killer Ds. Therapyis not model & technique.
Identity lies outside dx,prescriptive tx, cure, &reflects the interpersonalnature of the work & theconsumer’s perspective of thebenefit & fit of services.
www.heartandsoulofchange.com 4/3/2011
21
Data Could Help Here TooData Could Help Here Too
National data base couldreevaluate funding models& MM assumptions.
As evidence emerges redx, ESTs, LOS, & outcome,the real predictors maycome to light (alliance &early change).
Reimbursement based onbenefit
National data base couldreevaluate funding models& MM assumptions.
As evidence emerges redx, ESTs, LOS, & outcome,the real predictors maycome to light (alliance &early change).
Reimbursement based onbenefit
Bottom LineCollect DataBottom LineCollect Data
Nothing wrong with MM.But not empiricallysupported nor an aptdescription. Collect data &use it to introduce newconventions forunderstanding our services.Parity is fine but clientbenefit should be in themix.
Nothing wrong with MM.But not empiricallysupported nor an aptdescription. Collect data &use it to introduce newconventions forunderstanding our services.Parity is fine but clientbenefit should be in themix.
www.heartandsoulofchange.com 4/3/2011
22
Raving LunaticPsychotropicsRaving LunaticPsychotropics
Same as EBTs—whether anyapproach should be privilegedabove others, predictors, clientpreferences. None earned thatempirical respect.
Evidence: Meds should never beconsidered more than 1 optionamong many—never automatic.
Identity threat compelling: Justlike I am not a technicianadministering one size fits allinterventions, I am not a lowertiered way to help clients.
Same as EBTs—whether anyapproach should be privilegedabove others, predictors, clientpreferences. None earned thatempirical respect.
Evidence: Meds should never beconsidered more than 1 optionamong many—never automatic.
Identity threat compelling: Justlike I am not a technicianadministering one size fits allinterventions, I am not a lowertiered way to help clients.
Medication, Like All Treatments,Work Sometimes
Medication, Like All Treatments,Work Sometimes
Very studies purporting tosupport major classes ofdrugs reveal: limited efficacyof antidep. over placebo, theunderwhelming results ofantipsy. and their pervasiveintolerability, and a lack ofmeaningful benefit of combingtherapy and meds.
Regarding children, the datais even less compelling
Very studies purporting tosupport major classes ofdrugs reveal: limited efficacyof antidep. over placebo, theunderwhelming results ofantipsy. and their pervasiveintolerability, and a lack ofmeaningful benefit of combingtherapy and meds.
Regarding children, the datais even less compelling
www.heartandsoulofchange.com 4/3/2011
23
The APA Working Group on PsychoactiveMedications for Children and AdolescentsThe APA Working Group on PsychoactiveMedications for Children and Adolescents
For most of the disorders reviewed herein,there are psychosocial treatments that aresolidly grounded in empirical support as stand-alone treatments. Moreover, the preponderanceof available evidence indicates thatpsychosocial treatments are safer thanpsychoactive medications. Thus, it is ourrecommendation that in most cases,psychosocial interventions be consideredfirst. (p. 16.)
For most of the disorders reviewed herein,there are psychosocial treatments that aresolidly grounded in empirical support as stand-alone treatments. Moreover, the preponderanceof available evidence indicates thatpsychosocial treatments are safer thanpsychoactive medications. Thus, it is ourrecommendation that in most cases,psychosocial interventions be consideredfirst. (p. 16.)
Sparks, Duncan, Cohen, & Antonnucio,Fatal Flaws
Sparks, Duncan, Cohen, & Antonnucio,Fatal Flaws
Given the infiltration ofindustry influence,discerning good sciencefrom good marketingrequires a willingness toengage primary sources
Flaws cast doubt on claimsthat medication should be afirst line, a priori solution toany client problem.
Given the infiltration ofindustry influence,discerning good sciencefrom good marketingrequires a willingness toengage primary sources
Flaws cast doubt on claimsthat medication should be afirst line, a priori solution toany client problem.
www.heartandsoulofchange.com 4/3/2011
24
Five Fatal Flaws of Drug Studies
•Compromised blind
•Client versus clinician measures
•Time of measurement
•Conflicts of interest
•Minimization of risks
#1 Compromised Blind
DB foundation of RCT
Inactive placebos make itpossible to know txstatus (side effects)
Many experienced withmedications, and manyactively seek todetermine their status
Double blind integrity notmonitored
www.heartandsoulofchange.com 4/3/2011
25
#2 Client versus Clinician Ratings
Clients & clinicians differ onimpressions of improvement
Outcome measures are mostoften clinician-rated
When client ratings areused, no difference results
If clients don’t know they’rebetter, how much better arethey?
Doctor knows best!Doctor knows best!
#3 Time of Measurement
Medications are neverprescribed for shortperiods of time
8-12 week trialsinadequately determineeffect; differences startto dissolve by 16 weeks
Drug trial time frames:logistics or strategy?
www.heartandsoulofchange.com 4/3/2011
26
#4 Conflicts of Interest
When money speaks, the truth keepssilent.
Russian Proverb
#5 Minimization of Risks
Lack of standardizedmeasures for adverseevents; mostly fromspontaneous report
Lack of clarity of AEterminology
Failure to publishunfavorable studies
Rhetoric obscures data Conclusions for
tolerability and safetydo not reflect findings
This won’t hurt a bitThis won’t hurt a bit
www.heartandsoulofchange.com 4/3/2011
27
Flaws in Action: TADS(Treatment of Adolescent Depression Study)
Flaws in Action: TADS(Treatment of Adolescent Depression Study)
Multicenter, randomized,masked, effectiveness trialfunded by NIMH. N = 432
Short term (12-weeks) andlong-term (36-weeks) of 4tx for adols. dx MDD
Prozac, placebo, CBT,Prozac + CBT
Primary measures: CDRSand dichotomized CGI-I
Multicenter, randomized,masked, effectiveness trialfunded by NIMH. N = 432
Short term (12-weeks) andlong-term (36-weeks) of 4tx for adols. dx MDD
Prozac, placebo, CBT,Prozac + CBT
Primary measures: CDRSand dichotomized CGI-I
. . . a landmark government. . . a landmark government--financed study has found that Prozac helps teenagersfinanced study has found that Prozac helps teenagersovercome depression far better than talk therapy. But a combination of the two treatments,overcome depression far better than talk therapy. But a combination of the two treatments,the study found, produced the best result.the study found, produced the best result. NY Times, June 2, 2004NY Times, June 2, 2004
"The medication is addressing"The medication is addressingthe chemical imbalances in thethe chemical imbalances in thebrain while the psychotherapy isbrain while the psychotherapy isaddressing the behavior and theaddressing the behavior and thethoughts," said Dr. Timothythoughts," said Dr. TimothyWilens, a child psychiatrist atWilens, a child psychiatrist atMassachusetts General Hospital,Massachusetts General Hospital,who reviewed some of thewho reviewed some of thepreliminary results for ABCpreliminary results for ABCNews.News.
"The take"The take--home message is thathome message is thatmedication works, that suicidemedication works, that suiciderisk is minimal and that therisk is minimal and that thepositive effects of the medicinepositive effects of the medicineoutweigh the risk," saidoutweigh the risk," saidKoplewicz.Koplewicz. ABC News, June 2ABC News, June 2
Prozac effectiveProzac effective
The study's findings so far indicate that patientsThe study's findings so far indicate that patientsbecame less suicidal as the study advanced,became less suicidal as the study advanced,Emslie said in an interview. Nevertheless, theEmslie said in an interview. Nevertheless, therisk of suicide attempts was greater among thoserisk of suicide attempts was greater among thosetaking Prozac than those on placebo or talktaking Prozac than those on placebo or talktherapy: Five people on Prozac and one ontherapy: Five people on Prozac and one onplacebo made a suicide attempt, he said. Heplacebo made a suicide attempt, he said. Headded that the number of patients in the studyadded that the number of patients in the studywas too small to establish whether an increasedwas too small to establish whether an increasedrisk actually exists.risk actually exists. Newsday, June 3, 2004Newsday, June 3, 2004
"This study will help"This study will helpput the argument toput the argument torest," Emslie said.rest," Emslie said.
www.heartandsoulofchange.com 4/3/2011
28
TADSA Tad Short on Evidence
TADSA Tad Short on Evidence
Flaw #1: No active placebo; No placebocomparison for Comb.; CBT and Comb.knew tx status (no difference withplacebo).
Flaw #2: Primary measures clinician-rated. Secondary measures have limitedpsychometric credibility. 1 of 2 clinician-rated scales (CGI-I) at 12-weeks showsdifference. Primary measure shows nodifference. No effects client measures
Flaw #3: 12-week trial with limitedmasking; beyond 12 weeks, allparticipants knew treatment status. Nodifference at 30 weeks
Flaw #1: No active placebo; No placebocomparison for Comb.; CBT and Comb.knew tx status (no difference withplacebo).
Flaw #2: Primary measures clinician-rated. Secondary measures have limitedpsychometric credibility. 1 of 2 clinician-rated scales (CGI-I) at 12-weeks showsdifference. Primary measure shows nodifference. No effects client measures
Flaw #3: 12-week trial with limitedmasking; beyond 12 weeks, allparticipants knew treatment status. Nodifference at 30 weeks
TADSA Tad Short on Evidence
TADSA Tad Short on Evidence
Flaw # 4: Leadinvestigator, John March:support from Eli Lilly–extensive ties; Emslie andother researcher:consultants, speakersbureau, and researchsupport from Eli Lilly.
Flaw # 5: 6 suicideattempts out of 200 Prozactakers compared with 1 outof 200 non-Prozac takers.
www.heartandsoulofchange.com 4/3/2011
29
This Doesn’t MeanThat Meds Are Not Helpful
This Doesn’t MeanThat Meds Are Not Helpful
Just means thatmed. is no moreviable thananything else,client preferenceis paramount, notany empiricalmandate.
Just means thatmed. is no moreviable thananything else,client preferenceis paramount, notany empiricalmandate.
Penn, Schoen, & Berland Associates(2004). Survey for the APA. unpublishedpaper.
Prescription PrivilegesWell Intentioned but Dangerous
Prescription PrivilegesWell Intentioned but Dangerous
Psychiatrists weretrained as therapists.Despite lack of data &under the influence ofmassive marketing &increased income, mosthave become pillpushers. Arepsychologists different?
Psychiatrists weretrained as therapists.Despite lack of data &under the influence ofmassive marketing &increased income, mosthave become pillpushers. Arepsychologists different?
www.heartandsoulofchange.com 4/3/2011
30
Consider a Monitor FeatureThe Ability Not To PrescribeConsider a Monitor FeatureThe Ability Not To Prescribe
Thinking about how being able toprescribe has improved patientcare, he mentions a patientdiagnosed with bipolar disorder.Fain put him on acombination of medicationsno one had tried with himbefore. The medications broughtrelief from his manic symptomsfor the first time, Fain says.
"He tells me every time, he patsme on the shoulder and says,'You saved me.'"
Thinking about how being able toprescribe has improved patientcare, he mentions a patientdiagnosed with bipolar disorder.Fain put him on acombination of medicationsno one had tried with himbefore. The medications broughtrelief from his manic symptomsfor the first time, Fain says.
"He tells me every time, he patsme on the shoulder and says,'You saved me.'"
The Ability NOT to PrescribeThe Ability NOT to Prescribe
Such medication cocktails,SOP for psychiatry, areneither empirically supportednor FDA approved. Success ofthis client will likely lead tocontinue unsupported andunapproved poly-pharmaceutical solutions justlike psychiatrists—paving theway for the diminishment ofpsychotherapy as a first lineof action and furthermarginalization.
Such medication cocktails,SOP for psychiatry, areneither empirically supportednor FDA approved. Success ofthis client will likely lead tocontinue unsupported andunapproved poly-pharmaceutical solutions justlike psychiatrists—paving theway for the diminishment ofpsychotherapy as a first lineof action and furthermarginalization.
www.heartandsoulofchange.com 4/3/2011
31
Conclusions and DiscussionSparks et al
Conclusions and DiscussionSparks et al
When clinical trials are criticallyexamined…psychiatric drugtreatments should not be privileged.And when effects to tx are noted, whoprovides the tx, the quality of thealliance, and the clinician andrecipient’s expectations for successprovide a better explanation than anyspecific effects due to the medication.
Knowing that there is no irresistiblejustification to medicate, therapistsare free to put other options on thetable & draw in the voices of theirclients—to engage in an informedrisk/benefit analysis to choose txs inconcert with client values,preferences, & cultural contexts
When clinical trials are criticallyexamined…psychiatric drugtreatments should not be privileged.And when effects to tx are noted, whoprovides the tx, the quality of thealliance, and the clinician andrecipient’s expectations for successprovide a better explanation than anyspecific effects due to the medication.
Knowing that there is no irresistiblejustification to medicate, therapistsare free to put other options on thetable & draw in the voices of theirclients—to engage in an informedrisk/benefit analysis to choose txs inconcert with client values,preferences, & cultural contexts
Therapyshouldbe firstoption